Dr. Philip Gaffney is the CEO of Camgenium, a Cambridge based company specialising in medical device development and deployment. With over seventeen years of experience, Camgenium has been at the forefront of developing AI systems for medical devices. One of its key contributions is a widely deployed algorithm, developed in collaboration with C2-Ai, that helps manage NHS waiting lists and ensures patient safety by reducing the risks of long delays. As a recognised expert in the field, Dr. Gaffney leads the company in providing regulatory-compliant services for the design, validation and deployment of AI-driven medical devices.